AzTrials
AzTrials

Postpartum Depression (PPD)NCT07587177

mHealth Intervention to Prevent Postpartum Depression and Anxiety in Chilean Women (WWWT)

A study testing What Were We Thinking (WWWT) mHealth Intervention in people with Postpartum Depression (PPD) and Postpartum Anxiety, run by Universidad del Desarrollo.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the effectiveness of a digital psychoeducational intervention, "What Were We Thinking" (WWWT), to prevent the development of postpartum depression and anxiety symptoms in first-time mothers in Chile. Read more about this study

Who is it for?
Ages 18 years and older, women only
What is being tested?
What Were We Thinking (WWWT) mHealth Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
220 participants
Where
No sites listed yet
Study dates
1 May 2026to 31 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First-time mothers (primiparous women)
  • Aged 18 years or older
  • Having a healthy, full-term infant younger than 2 months of age
  • Receiving prenatal or postnatal care at participating primary health centers in Chile
  • Having access to a mobile phone capable of receiving calls and text messages
  • Able to understand and communicate in Spanish

Who cannot join

  • Severe symptoms of depression or anxiety at baseline requiring immediate specialized mental health treatment
  • Severe psychosocial problems (e.g., substance abuse, domestic violence, significant cognitive impairment)
  • Infant born preterm or with severe medical conditions (e.g., genetic disorders or serious neonatal complications)
  • Inability to provide informed consent or participate in study procedures due to language or cognitive barriers

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Soledad Coo, PhD contact

+56 9 9075 3976

scoo@udd.cl

About this study

Official title: WHAT WERE WE THINKING" (WWWT) PROGRAM: A DIGITAL INTERVENTION TO PREVENT POSTPARTUM DEPRESSION AND ANXIETY IN CHILEAN WOMEN

The goal of this clinical trial is to evaluate the effectiveness of a digital psychoeducational intervention, "What Were We Thinking" (WWWT), to prevent the development of postpartum depression and anxiety symptoms in first-time mothers in Chile. The study includes adult women with a healthy, full-term infant younger than two months who are receiving care in primary health centers.

The main questions it aims to answer are:

Read more
  • Does participation in the WWWT intervention reduce depressive and anxiety symptoms at 3 months after the end of the intervention compared to usual care?
  • Does participation in the intervention improve maternal self-efficacy, perceived social support, and coparenting relationship quality compared to usual care? Researchers will compare an experimental group receiving the full WWWT intervention with a control group receiving usual care to determine the effectiveness of the intervention.

Participants will:

  • Complete self-report questionnaires assessing depressive symptoms, anxiety symptoms, maternal self-efficacy, perceived social support, and coparenting at baseline and at 3-month follow-up
  • Be randomly assigned to either the intervention group or the control group
  • Receive the WWWT intervention between 4 and 10 weeks postpartum (intervention group), including:
  • Fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks
  • Individual contact with a trained facilitator through text messaging
  • One virtual group session with other mothers and a facilitator
  • Continue receiving usual care in primary health services (control group) and receive a shortened version of the intervention after the follow-up assessment
Read the detailed description

Postpartum depression and anxiety are common mental health conditions that affect women during the transition to motherhood and have significant consequences for maternal well-being, parenting, and infant development. In Chile, a substantial proportion of women report elevated depressive and anxiety symptoms during the postpartum period. Despite the implementation of universal screening strategies in primary health care, access to mental health treatment remains limited, as many women identified as at risk do not engage in or receive appropriate care. This gap highlights the need for preventive interventions that can be delivered early and at scale.

Preventive psychosocial interventions targeting modifiable risk factors, such as maternal self-efficacy and perceived social support, have shown effectiveness in reducing the risk of developing postpartum mental health difficulties. However, engagement in face-to-face interventions is often low. In this context, digital health (e-mental health) and mobile health (mHealth) interventions offer a promising alternative, particularly in settings with high mobile phone access and limited mental health resources. Guided digital interventions that include human support have demonstrated higher adherence and effectiveness compared to unguided formats.

"What Were We Thinking" (WWWT) is a psychoeducational, preventive intervention originally developed in Australia to reduce the risk of postpartum depression and anxiety among first-time mothers. The intervention targets key modifiable risk factors, including maternal self-efficacy in infant care and the quality of partner support. The program has been culturally adapted for use in Chile and further adapted to an mHealth format to facilitate delivery through mobile phones.

The Chilean mHealth version of WWWT includes three main components: (1) fourteen brief psychoeducational video modules (3-5 minutes each) delivered via text messaging over a period of 4 to 5 weeks, each accompanied by reflective prompts; (2) asynchronous communication with a trained facilitator through text messaging to provide guidance, answer questions, and support engagement; and (3) one virtual group session with other participating mothers led by the facilitator. The intervention is delivered between 4 and 10 weeks postpartum. Facilitators are trained health professionals (e.g., psychologists, midwives, nurses) with knowledge in perinatal mental health, and they are also responsible for referring participants to primary care services when needed.

A previous feasibility study conducted in Chile demonstrated high acceptability and feasibility of the mHealth WWWT intervention, as well as positive perceptions among participants regarding its usefulness for maternal well-being and partner involvement. Preliminary findings suggested that the intervention may be particularly beneficial for women presenting with mild symptoms at baseline, consistent with its preventive focus. However, no significant differences were found between intervention and control groups in overall symptom levels, possibly due to elevated baseline distress during the COVID-19 pandemic. Therefore, further research is needed to evaluate the effectiveness of the intervention under non-crisis conditions and in a larger sample.

The present study is a randomized controlled trial with two parallel arms (intervention and control) designed to evaluate the effectiveness of the WWWT intervention in preventing postpartum depression and anxiety symptoms. Participants are first-time mothers with infants younger than two months receiving care in primary health centers in Chile. After baseline assessment, participants are randomly assigned (1:1) to either the intervention group, which receives the full WWWT program, or the control group, which receives usual care. Follow-up assessments are conducted 3 months after completion of the intervention.

Primary outcomes include depressive and anxiety symptoms. Secondary outcomes include maternal self-efficacy, perceived social support, and coparenting relationship quality. Outcomes are assessed using validated self-report measures administered online at baseline and follow-up.

This study will provide rigorous evidence on the effectiveness of a scalable, culturally adapted digital preventive intervention for postpartum mental health in a Latin American context. Findings may inform the integration of mHealth interventions into primary health care services and contribute to improving maternal mental health and early child development outcomes.

Being tested
What Were We Thinking (WWWT) mHealth Intervention
Keywords
Postpartum depression prevention, Postpartum anxiety prevention, Perinatal mental health, First-time mothers, mHealth intervention, Randomized controlled trial, Chile, What Were We Thinking (WWWT)
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • What Were We Thinking (WWWT) mHealth InterventionBehavioural

    The "What Were We Thinking" (WWWT) is a psychoeducational, preventive mHealth intervention designed for first-time mothers to reduce the risk of postpartum depression and anxiety. The intervention targets modifiable risk factors, including maternal self-efficacy in infant care and perceived social support. It is delivered between 4 and 10 weeks postpartum and includes three components: (1) fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks, accompanied by reflective prompts; (2) asynchronous support from a trained facilitator via text messaging; and (3) one virtual group session led by the facilitator. Facilitators are trained health professionals and can refer participants to primary care services when needed.

Study groups in NCT07587177
Study groupRoleWhat they receive
WWWT InterventionExperimentalParticipants receive the full "What Were We Thinking" (WWWT) mHealth intervention between 4 and 10 weeks postpartum. The intervention includes 14 psychoeducational video modules delivered via text messaging over 4-5 weeks, asynchronous support from a trained facilitator via text messages, and one virtual group session. Participants also continue receiving usual primary health care.
Receives: Behavioral: What Were We Thinking (WWWT) mHealth Intervention
Usual CareNo interventionParticipants receive usual care provided by primary health services. They do not receive the WWWT intervention during the study period. After completion of the follow-up assessment, participants are offered a shortened version of the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postpartum depressive symptoms

    Depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS)

    Measured: Baseline and 3 months after completion of the intervention

  2. Postpartum anxiety symptoms

    Anxiety symptoms assessed using the Depression, Anxiety and Stress Scales (DASS-21)

    Measured: Baseline and 3 months after completion of the intervention

Secondary outcomes (3)
  1. Maternal self-efficacy

    Maternal self-efficacy assessed using the Escala de Evaluación Parental (EEP)

    Measured: Baseline and 3 months after completion of the intervention

  2. Perceived social support

    Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS)

    Measured: Baseline and 3 months after completion of the intervention

  3. Satisfaction with coparenting

    Satisfaction with coparenting assessed using the Escala de Evaluación Parental (EEP)

    Measured: Baseline and 3 months after completion of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2026
  2. Study start1 May 2026 (estimated)
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
220 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07587177
Sponsor's protocol ID
COO-2026
Status last verified
Apr 2026
First submitted
8 May 2026
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) will be shared upon reasonable request after publication of the primary study results. Data that may be shared include participant-level outcome data, baseline characteristics, and study-related variables. Identifiable information will be removed to ensure confidentiality. Requests for data access will require approval by the principal investigator and may be subject to a data sharing agreement. Data will be made available for academic research purposes only.

Publications

  • Coo S, Garcia MI, Perez JC, Aldoney D, Olhaberry M, Fernandez O, Alamo N, Franco P, Perez F, Fernandez S, Fisher J, Rowe H. Online Intervention Targeting Postnatal Depression and Anxiety in Chilean First-Time Mothers: Feasibility Trial. J Pediatr Psychol. 2024 Apr 15;49(4):266-278. doi: 10.1093/jpepsy/jsad086.

    PubMed 38070171
  • Coo S, Garcia MI, Awad N, Rowe H, Fisher J. Cultural adaptation of an intervention to prevent postnatal depression and anxiety in Chilean new mothers. J Reprod Infant Psychol. 2021 Jul;39(3):276-287. doi: 10.1080/02646838.2019.1705264. Epub 2019 Dec 17.

    PubMed 31847567

Questions about this trial

What is this clinical trial studying?

A study testing What Were We Thinking (WWWT) mHealth Intervention in people with Postpartum Depression (PPD) and Postpartum Anxiety, run by Universidad del Desarrollo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Soledad Coo, PhD (+56 9 9075 3976, scoo@udd.cl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postpartum depressive symptoms (time frame: Baseline and 3 months after completion of the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07587177, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in